Frontiers in Oncology | Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Original Research

Published on 05 Sep 2025

Preoperative assessment of longitudinal extent in hilar cholangiocarcinoma using noninvasive enhanced MR radiomics: a multicenter study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xin Quan
Xinqiao Huang
Jiong Liu
Xiang Yuan
Jian Shu

Frontiers in Oncology

doi 10.3389/fonc.2025.1632630

348 views

Original Research

Published on 05 Sep 2025

A pan-cancer perspective analysis reveals the prognostic significance of SLC7A11 in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yinxu Zhang
Dai Wang
Xiaoyang Chen
Yuxi Wang
Guangyu Zhang
Xiaomei Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1601140

341 views

Case Report

Accepted on 04 Sep 2025

Curative Response to Combined Targeted-Immunotherapy for Post-Hepatectomy Lymph Node Metastasis in Sarcomatoid Hepatocellular Carcinoma: Case Report and Literature Review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Pan Liu
Song Zhang
Xiao-Ming Xin
Min Jing
Lie-Dong Wen
Xin Xiang
Shun-Hai Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1591419

383 views

Review

Accepted on 04 Sep 2025

Efficacy and safety of antiangiogenic agents combined with HIFU in the treatment of advanced liver cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Rong Wu
ling qiu Shi
biao dong Liao
yao liao
feng sun
yu he
yang pei mao
li ling fan
xi yu bai
gang feng

Frontiers in Oncology

doi 10.3389/fonc.2025.1652434

159 views

Case Report

Accepted on 03 Sep 2025

Molecular profiling of circulating tumor cells guides effective EGFR inhibitor treatment in advanced hepatocellular carcinoma: A case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Wei Chiu
SAN-CHI CHEN
Yee Chao
Jan-Mou Lee

Frontiers in Oncology

doi 10.3389/fonc.2025.1608604

276 views

Case Report

Published on 03 Sep 2025

Case Report: Tumor lysis syndrome in advanced, massive hepatocellular carcinoma with main portal vein invasion following atezolizumab plus bevacizumab therapy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Tien-Shin Chou
Chun-Feng Wu
Chih-Lang Lin
Chao-Wei Hsu

Frontiers in Oncology

doi 10.3389/fonc.2025.1624908

435 views

Original Research

Published on 03 Sep 2025

Recurrence of hepatocellular carcinoma in patients with high HALP score in TACE combined with ablation

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Da Fang
Xue Yin
Xiaoyan Ding
Jinglong Chen
Xiongwei Cui
Caixia Hu

Frontiers in Oncology

doi 10.3389/fonc.2025.1609260

293 views

Original Research

Accepted on 02 Sep 2025

TFF2, a novel serum diagnostic biomarker for early Pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xiangyu Wu
Xiuhong Huang

Frontiers in Oncology

doi 10.3389/fonc.2025.1633069

239 views

Original Research

Published on 02 Sep 2025

Significantly higher incidence of circulating fatty objects in portal blood samples compared to peripheral blood samples in patients with pancreatic ductal adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Ruoxiang Wang
Kenneth Park
Srinivas Gaddam
Quin Liu
Rabindra Watson
Adrian Lim
Yan Ou
Yi Zhang
Mouad Edderkaoui
Michael S. Lewis

Frontiers in Oncology

doi 10.3389/fonc.2025.1611872

745 views

Original Research

Accepted on 29 Aug 2025

Identification of amino acid metabolism-related gene Leucyl-tRNA synthetase 1 (LARS1) as a potential prognostic and therapeutic target in hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qiyu Shi
Yirong Chi
Ziyi Peng
Chao Li
Jingwen Zhao
Jie Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1675018

166 views

Review

Accepted on 29 Aug 2025

Decoding the Microbial-Local Immune Dialogue in Liver Cancer: From Ecological Drivers to Precision Therapeutics

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Shu Liu
Yichi Xu
Bo Wen
Nan Gao

Frontiers in Oncology

doi 10.3389/fonc.2025.1629479

139 views

Original Research

Accepted on 29 Aug 2025

The Combination Treatment of Oncolytic Adenovirus H101 with Transcatheter Arterial Embolization Sequential Thermal Ablation for Hepatocellular Carcinoma: A Retrospective Study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Changyou Jing
Tong Zhu
Yonghong Zhang
Jianjun Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1623877

183 views

Original Research

Published on 29 Aug 2025

Efficacy and liver function preservation with donafenib combined with transarterial chemoembolization in unresectable hepatocellular carcinoma: An ALBI grade analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Jinpeng Li
Yan Li
Yuanming Li
Jiasheng Du
Lujun Zhao
Jingtao Zhong

Frontiers in Oncology

doi 10.3389/fonc.2025.1612477

481 views

Case Report

Published on 28 Aug 2025

Case Report: Concurrent two adenomatoid tumors of liver

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Lei Bi

Frontiers in Oncology

doi 10.3389/fonc.2025.1640018

444 views

Original Research

Published on 27 Aug 2025

ISG15 mRNA transcript level in circulating leucocytes prognostic of overall survival in hepatocellular carcinoma patients and correlated with quality of life disturbances involved in anorexia-cachexia

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Leung Li
Nelson L. S. Tang
Frankie Mo
Jane Koh
Edwin P. Hui
Brigette Ma
Stephen L. Chan
Kit F. Lee
Simon C. H. Yu
Winnie Yeo

Frontiers in Oncology

doi 10.3389/fonc.2025.1589053

1,349 views

Original Research

Published on 27 Aug 2025

Comparison of Albumin-Bilirubin, Platelet-Albumin-Bilirubin, and Child-Pugh scores to predict overall survival in patients with stage C hepatocellular carcinoma with liver cirrhosis treated with c-TACE

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Fei Wu
Zhihong Zhang
Shanshan Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1613697

626 views